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ABSTRACT
Herpes simplex virus, varicella zoster virus, human cytomegalovirus, and rubella virus are the most common
causes of virus-induced anterior uveitis. They can present in a variety of entities not only with typical but also
overlapping clinical characteristics. These viral infections are commonly associated with ocular inﬁltration of T
cells and B/plasma cells, and expression of cytokines and chemokines typical of a proinﬂammatory immune
response. The infections differ in that the herpes viruses cause an acute lytic infection and inﬂammation, whereas
rubella virus is a chronic low-grade infection with slowly progressing immunopathological responses. The
outcome of an intraocular viral infection may largely be guided by the characteristics of the virus, which
subsequently dictates the severity and type of the immune response, and the host immune status.
Keywords: Cytomegalovirus, herpes simplex virus, immunopatholog, rubella virus, varicella zoster virus
Virus-induced anterior uveitis is a combination of a
viral infection and resulting antiviral inﬂammatory
responses in the eye. In general, the virus will infect
permissive ocular cells, which may differ for every
virus. This will induce an innate immune response
including the release of cytokines and chemokines,
which will subsequently attract immune cells, such
as neutrophils, natural killer (NK) cells, T and B
cells, which will further contribute to the inﬂamma-
tion by for instance secreting more inﬂammatory
cytokines and chemokines and/or by exerting cyto-
toxicity toward virus-infected cells. On the other
hand anti-inﬂammatory cytokines and regulatory T
cells may be present, which presumably counteract
the inﬂammation. Depending on the characteristics
of the virus, the immune status and most likely also
the genetic make-up of the patient the resulting
uveitis may vary in severity and outcome. The
most prevalent causes of virus-induced anterior
uveitis are herpes simplex virus (HSV), varicella
zoster virus (VZV), human cytomegalovirus
(HCMV), and rubella virus.1 Other viruses are also
known to cause or are associated with anterior
uveitis, such as chickungunya virus, dengue virus,
inﬂuenza virus H1N1, parechovirus, and parvo-
virus B19;2–5 however, immunopathology in
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relation to these viruses is reported only limitedly.
This article will therefore focus on the main viral
causes: HSV, VZV, HCMV, and rubella virus.
HERPETIC ANTERIOR UVEITIS
The human neurotropic alphaherpesviruses, HSV type 1
(HSV-1) and particularly VZV, are the most common
infectious causes of anterior uveitis in otherwise healthy
individuals, accounting for 5–10% of cases in the
Western world.6,7 Herpetic anterior uveitis (HAU)
usually follows an acute recurrent course, is typically
unilateral, and associated with blurred vision, eye pain,
photophobia, redness, the presence of keratic precipi-
tates, elevated intraocular pressure (IOP), and sectoral
iris atrophy.7–9 Compared to HSV-1-associated HAU,
VZV anterior uveitis is more commonly diagnosed in
older individuals and more frequently associated with
conjunctival redness, corneal edema, posterior syne-
chiae, vitritis, and higher IOP.8–10 The visual prognosis
of HAU, when diagnosed promptly and if treated cor-
rectlywith speciﬁc antiviral therapy and topical steroids,
is favorable.8,9 Because no speciﬁc clinical parameters are
known to differentiate HSV-1 and VZV anterior uveitis,
diagnosis of HAU is challenging particularly when
patients show no typical clinical signs or recent history
of herpetic diseases like HSV-1 keratitis and herpes zos-
ter ophthalmicus.6–9 Clinical examination of aqueous
humor (AH), showing cellular activity and ﬂare, and
laboratory analysis of AH to detect herpesvirus-speciﬁc
DNA and local antibody production in the diseased eye
are advocated to determine the severity and etiology of
anterior uveitis, respectively.8,11,12 Because the patient’s
immune status and duration of disease affect the out-
come of either diagnostic assay, both assays should ide-
ally be performed in parallel.7–9,11Whereas early at onset
of disease viral DNA is readily detectable and local anti-
body absent, the reverse outcome ismore commonwhen
AH is sampled at later times after onset of disease.
Furthermore, local antibody production is rarely contri-
butive to the differential diagnosis in severely immuno-
compromised uveitis patients.8,11,12
While the majority of adults are latently infected
with HSV-1 and VZV, only a limited number of
latently infected individuals will develop HAU.
Various factors that determine the incidence and spec-
trum of ocular herpetic diseases are immune status,
age, genetic predisposition, time and route of infection,
and potentially the virus strain.6–8,13 HSV-1 and VZV
are endemic worldwide infecting about 70% and >90%
of individuals, respectively.14 Upon primary infection,
commonly during early childhood, both viruses estab-
lish a lifelong latent infection in sensory and auto-
nomic neurons from which they reactivate leading to
regular asymptomatic virus shedding and incidentally
recurrent disease of variable clinical severity ranging
from cold sores and shingles to potentially sight-
(keratitis and uveitis: both viruses) or even life-threa-
tening neurological diseases (HSV-1 encephalitis).14,15
Intra-ganglionic innate (neuron-interacting satellite
glial cells) and adaptive immunity (T cells) are essen-
tial to control herpesvirus latency in neurons. Whereas
innate immunity is most likely sufﬁcient to prevent
VZV to escape from latency, HSV-1-speciﬁc CD8 T
cells are of additional importance to prevent HSV-1
reactivation.14,16–18 Because most if not all HAU
patients have already antibodies to the triggering her-
pesvirus and latency has not been detected in ocular
tissues,11,19 the disease is not initiate by a primary
infection but most likely due to reactivation of endo-
genous virus that entered the eye via trans-axonal
transport from the innervating sensory or autonomic
ganglia.7,10 The independent distribution of latent
HSV-1 and VZV in these ganglia, particularly the dis-
similarity in latent virus between paired left and right
ganglia of the human head and neck, may explain the
clinical observation that HAU usually occurs
unilaterally.20,21
Due to the lack of animal models that appropriately
mimic the pathogenesis of HAU, especially VZV that
does not productively infect nonhuman cells, current
knowledge on the virus and host factors involved in
the disease process is largely based on laboratory stu-
dies performed on surplus AH samples of HAU
patients.7–10,14 Whereas these studies provided impor-
tant insight into the cell types and mediators involved
during fulminant HAU, inevitably no information was
obtained on key parameters that coordinate the initia-
tion and resolution phase of HAU. This information is
at least of equal importance to develop novel interven-
tion strategies aimed to block disease progression and
prevent recurrences.8,10,14 The association between tim-
ing of AH sampling and the differential presence of
herpesvirus DNA and local antibody production11 hint
at the prominent role of a direct cytopathic effect (CPE)
of the virus on ocular tissue resident cells and an
immune-mediated pathology during the early and
more progressed clinical phase of HAU, respectively.
The correlation between intraocular VZV load and IOP
may be due to an obstruction of aqueous outﬂow due
to viral CPE on the trabecular meshwork, whereas the
beneﬁcial effect of corticosteroid treatment supports the
detrimental role of a local inﬂammatory response in
HAU pathogenesis.8,10,14 Anterior chamber inﬂamma-
tion in HAU can vary from mild-to-severe inﬂamma-
tion ultimately leading to hypopyon formation, which
represents a dense leukocyte sediment at the bottom of
the anterior chamber. AH of HAU patients is devoid of
neutrophils and predominantly contains T cells.
Compared to paired blood, AH-derived T cells are pre-
dominantly memory CD8 T cells expressing the activa-
tion marker Human leukocyte antigen-DR (HLA-DR)
implicating their direct role in HAU pathogenesis.22
Detailed phenotypic and functional studies on short-
term cultures of AH-derived T cells of HAU patients
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demonstrated that they speciﬁcally recognized the trig-
gering herpesvirus.23 These virus-speciﬁc T cells, both
CD4 and CD8 T cells, expressed a T0/T1 phenotype
and killed virus-infected cells in vitro demonstrating
their potential uveitogenic properties.23,24 These data
match the cytokine expression proﬁles in AH of HAU
patients, implicating that T cells are the major source of
tumor necrosis factor alpha (TNF-α) and interferon
gamma (IFN-γ), antiviral cytokines that can also med-
iate deleterious inﬂammatory responses.25,26 In addition
to inﬂammatory cytokines, interleukin 10 (IL-10) levels
are also elevated in AH from infectious uveitis patients.
The signiﬁcance and cellular source of this inhibitory
cytokine in HAU patients is unclear.25,26 T-cell reactivity
to the non-causative human alphaherpesvirus is also
detected in the affected eyes of herpetic uveitis
patients,23 suggesting the role of cross-reactive T cells
in the disease. The identiﬁcation of CD4 T-cell clones,
cultured from AH of a VZV uveitis patient, which
recognized both VZV- and HSV-1-infected cells, sup-
ports this hypothesis.27 Moreover, the respective VZV/
HSV-1 cross-reactive CD4 T cell epitope bound with
high afﬁnity to multiple HLA-DR alleles and was read-
ily recognized by blood-derived T cells of multiple
healthy adults. These type of herpesvirus cross-reactive
CD4 T cells may be beneﬁcial to combat HSV-1 and
VZV infection in skin but may be detrimental upon
inﬁltration and activation in ocular tissues infected
with either herpesvirus.27 In conclusion, HSV-1 and
VZV are common causes of anterior uveitis with a
good prognosis if treated appropriately to control both
intraocular virus replication and virus-speciﬁc T cell-
mediated immunopathology.
CMV ANTERIOR UVEITIS
HCMV is a double-stranded DNA virus and is a mem-
ber of the Herpesviridae family.28–30 Productive HCMV
ocular infections are more commonly present as a
retinitis in immunocompromised patients31,32 but are
increasingly recognized as a cause of anterior uveitis,
corneal endotheliitis, and corneal graft failure in
immunocompetent individuals.29,33–37 Chronic CMV
anterior uveitis may present as a Fuchs heterochromic
cyclitis or with acute IOP spikes similar to Posner–
Schlossman syndrome (PSS).38,39 During such IOP
spikes, studies have shown that CMV DNA can be
detected and quantiﬁed by real-time polymerase
chain reaction analysis, indicating that the reactivation
of the CMV infection can be correlated to clinical
inﬂammation and IOP elevation.36 However, these
studies also demonstrate the transient nature of this
reactivation which is demonstrated by false negative
results due to delayed testing.36
HCMV is capable of infecting a variety of cell types
including ocular cells, such as retinal cells, keratocytes,
glial, and inﬂammatory cells.28–32,40 After initial
infection, the HCMV genome enters the cell nucleus
and leads to a variety of viral gene transcriptions from
immediate early genes to late genes resulting in produc-
tion of infectious particles.28,30,41,42 The outcome of
HCMV replication leads to lytic HCMV infection and
depending on the cell type that is infected can result in
lifelong latency. Latent infection is known to establish in
monocytes and CD34+ cells of myeloid lineage.28,30,42,43
Both the innate and adaptive immunity play a role in the
host defense against HCMV infections.
Toll-like receptors (TLRs) are components of the
innate immunity and TLR2 has been shown to interact
speciﬁcally with the HCMV glycoproteins B and gH
resulting in activation of the innate immune system.30
In murine CMV infection, TLR4 and 9 were also shown
to be involved.44 Once the innate response is activated,
inﬂammatory cytokines and interferons are produced
and co-stimulatory molecules are upregulated.
Antigen-presenting cells (APCs) and NK cells are also
activated to prime the adaptive immunity.28,30,41 NK
cells are thought to bridge the innate and adaptive
immune system and their role in CMV infection is
increasingly being recognized.30
HCMV-derived peptides are processed by APCs
and result in a strong adaptive immune response
involving both humoral and cellular immunity.30,41
The main cellular mediators against HCMV infections
are CD4 and CD8 T cells which recognize peptides
presented by MHC Class II and Class I molecules,
respectively.41 Once activated, they proliferate and
differentiate to effector T cells that secrete cytokines
and may destroy the CMV virus-infected cells.30 The
humoral immune response is characterized by the for-
mation of speciﬁc antibodies to HCMV structural and
nonstructural viral proteins, which contribute to
restriction of viral dissemination and its clinical man-
ifestations. In immunocompetent individuals, the
adaptive immunity is important for control of HCMV
latency aimed to prevent reactivation. During CMV
latency, CMV-speciﬁc T cells persist as memory T
cells that continue to expand and become activated to
production interferon-gamma (IFN-γ) and a Th1 cyto-
kine signature upon viral reactivation. In individuals
with impaired T-cell immunity, such as in retrovirus
infection (AIDS) and solid organ or bone marrow
transplantation, the risk of HCMV reactivation is
increased due to T-cell impairment and with that the
clinical manifestation of HCMV retinitis rather than
anterior uveitis or endotheliitis.30,41
Intraocular CMV infections have been studied in mice
using MCMV.43,45–47 In immunocompetent mice, MCMV
intraocular infection presents as an anterior uveitis char-
acterized by inﬂammatory cells within the iris and ciliary
bodywithout accompanying retinitis.43,45,46 In these cases,
MCMVDNAwas detected by in situ hybridization in the
cornea, ciliary body, and iris early after viral infection,
whereas only occasional viral DNA was detected in the
choroid and transiently in the retina.43,45,46 MCMV
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retinitis did not develop until immunosuppression was
instigated.45 In systemic MCMV infection, the virus was
detected in the anterior segment less frequently than with
intraocular inoculation or immunosuppression.47 These
data suggest that other factors, such as blood retinal bar-
rier breakdown and altered immune responses, are neces-
sary for a productive ocular MCMV infection. In contrast,
when immunosuppression was induced in immunocom-
petent MCMV-infected mice, necrotizing retinitis devel-
oped suggesting that the route of MCMV retinal infection
was via the ciliary body and choroid.45 The presence of
MCMV DNA in the retinal pigment epithelium and ret-
inal outer nuclear layers in early infections supports this
theory.45,46 In addition, in immunosuppressed mice, cor-
neal keratocytes appeared to be infected via limbal vessels
but this did not cause clinical corneal pathology.47
Macrophages and its precursor monocytes are
thought to harbor MCMV in systemic infection and
aid spread to other organs, yet these murine studies
also revealed that when macrophages were depleted,
viral dissemination still occurred demonstrating that it
was not macrophage dependent.47 As previously men-
tioned, T and B cells have also been shown to harbor
MCMV and can be a potential source of latency.43 It is
interesting to note that MCMV DNA could be detected
in ocular ﬂuids and tissues, particularly in the ciliary
body and iris, as long as 3–4 months post-infection and
suggests that the anterior uvea may represent a poten-
tial reservoir for latent MCMV.45,46
Although there is a paucity of knowledge in the
pathogenesis of anterior CMV uveitis in immunocom-
petent individuals, we are beginning to ﬁnd similari-
ties to the MCVM model.45,46 HCMV-associated owl’s
eye inclusions have previously been demonstrated in
the cornea stroma and endothelium in patients with
HCMV endotheliitis by in vivo confocal microscopy as
well as HCMV DNA by real-time polymerase chain
reaction (qPCR) in anterior chamber ﬂuid.33,34
Moreover, a recent study by Chan et al. demonstrated
HCMV viral protein expression in the cornea and iris
that appears to support the MCVM anterior uvea
latency theory.29 In HCMV graft-related infections,
CMV-antigen-positive endothelial cells were found
by immunohistochemistry (Figure 1C), conﬁrming the
presence of an underlying HCMV-induced
endotheliitis.29 Furthermore, diffuse stromal involve-
ment characterized by HCMV-infected keratocytes
was demonstrated (Figure 1A and B). The location of
the HCMV infection in the cornea seen at the limbus29
seems to reﬂect the ﬁndings in the MCMV immuno-
suppression model.47 Indeed, the majority of the
patients with corneal HCMV endotheliitis or keratitis
have had local or systemic immunosuppressive ther-
apy. Similar to HCMV retinal studies, co-localization
of HCMV-infected cells with CD68-positive macro-
phages was not found.29 Finally, CD163 type 2 macro-
phages showed close association with CMV-infected
keratocytes suggesting that rather than harboring the
virus, these macrophages may play a role in the immu-
nopathology of CMV graft infection (Figure 1D).
Chronic HCMV uveitis is associated with iris stromal
atrophy.36,37 Iris iridectomy specimens from patients
with previous qPCR-positive HCMV anterior uveitis
show stromal atrophy with a relatively intact posterior
iris pigment epithelium (Figure 2A; Chan et al., unpub-
lished data). Immunohistochemical (IHC) analysis for
HCMV antigens showed variable atypical staining in
FIGURE 1. Immunohistochemistry on corneal tissue removed
during penetrating keratoplasy from patients with CMV graft
infection. (A,B) Histology (hematoxylin and eosin stain 20×,
40×): Viral cytopathic changes are characterized by cellular
enlargement (up to 2 times a normal keratocyte) with eosinophi-
lic intranuclear and intracytoplasmic inclusions. Note the signif-
icant lack of inﬂammation and vascularisation as seen in other
herpetic keratitis. (C) CMV immunohistochemistry, 40× (Dako,
USA with alkaline phosphatase red chromagen) demonstrating
CMV antibody staining in the endothelial cells conﬁrming the
presence of CMV endotheliitis. (D) Dual CMV and CD163
macrophage (Dako, USA) immunohistochemistry (40×) with
alkaline phosphatase red chromagen, CMV antibody, and
brown diaminobenzidine staining for CD163 shows no coloca-
liztion of CD163 with CMV demonstrating that CMV is not
latent in macrophages.
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some iris pigment epithelial cells characterized by only
cytoplasmic staining (Figure 2B and C), unlike active
HCMV-positive controls where both nuclear and cyto-
plasmic immunoreactivity were observed (Figure 1D).
HCMV-speciﬁc qPCR of these irides is commonly nega-
tive. Light microscopy also does not show the typical
cytomegaly of CMV CPE. The clinical signiﬁcance of
such staining pattern has yet to be explored. A possible
explanation might be cross-reactivity of HCMV proteins
with iris proteins. Alternatively, itmay be due to staining
of viral protein remnants in the cytoplasm. The question
whether HCMV DNA can be eradicated post-infection,
but not the CMV protein, remains unanswered but is of
interest for future studies. Immunohistochemistry for
other inﬂammatory cell markers in these post-CMV
irides showed incidental CD3 T cells and CD68 macro-
phage inﬁltrates suggesting the presence of a subclinical
chronic inﬂammatory response (Figure 2D and E).
Little data are available on intraocular cytokines in
CMV anterior uveitis. The AH of immunocompetent
patients with HCMV anterior segment infections was
reported to have signiﬁcantly higher levels of IL-5, IL-6,
IL-8 (CXCL8), monocyte chemotactic protein-1 (MCP-1;
CCL-2), macrophage inhibitory protein-1β (MIP-1β;
CCL-4), granulocyte colony stimulating factor, and
transforming growth factor-β, but low levels of IL-2, IL-
12, TNF-α, and INF-γ compared to the control groups.48,49
Interestingly, no signiﬁcant difference in aqueous cyto-
kines was detected in HCMV qPCR-positive immuno-
competent PSS patients when compared to HCMV
qPCR-negative PSS patients.49 Future studies are war-
ranted to provide better insights into the inﬂammatory
response or intraocular milieu that may potentiate
HCMV anterior segment infection.
In conclusion, HCMV infection induces a profound
immune response involving both innate and adaptive
immunity. Impairment of both, and in particularly the
virus-speciﬁc T-cell response, can induce HCMV reactiva-
tion. In immunocompetent mice and humans, CMV pre-
sents a transient, self-limiting viral infection that
predominantly occurs in the anterior uvea presenting as
an anterior uveitis or corneal endotheliitis. In latent or
chronic CMV infections, viral DNA has been detected in
the anterior uvea of murine CMV models, even several
months after initial infection suggesting that it may be a
potential reservoir of latent CMV. An intraocular immu-
nocompromised state may result in the reactivation of
CMV. Case reports have described HCMV reactivation
in patients using topical cyclosporine A or with ocular
corticosteroid implants.50,51 Both of these drugs are
FIGURE 2. Immunohistochemistry on iris iridectomy specimens from patients with chronic CMV anterior uveitis. (A) Histology
(hematoxylin and eosin stain 20×): Iris iridectomy specimen showing stroma ﬁbrosis and atrophy (+). The posterior iris pigmented
epithelium remains relatively intact (*). Viral cytopathic changes characterized by cytomegalic cells with eosinophilic nuclear and
cytoplasmic inclusions are absent. Rare inﬂammatory cells may be seen within the stroma. (B) Low power view of CMV immunohis-
tochemistry (20×, alkaline phosphatase red chromagen) highlights the atypical CMV antibody in occasional cells (blue arrow). (C)
Higher power view of CMV immunohistochemistry (40×, alkaline phosphatase red chromagen) reveals that the CMV antibody staining
is limited to the cytoplasm (blue arrows) only without the nuclear staining seen in the positive controls. (D) CD3, T-cell immunohis-
tochemistry (40×) with alkaline phosphatase red chromagen highlights the presence of rare T cells (blue arrow). (E) CD68, macrophage
immunohistochemistry (40×) with alkaline phosphatase red chromagen highlights the presence of rare macrophages (blue arrow).
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known to suppress T-cell immunity, which is crucial in
inhibiting CMV reactivation.52,53 Understanding the
immunopathogenesis of CMV ocular infections is vital




Rubella virus is a positive-stranded RNA virus and the
only member of the Rubivirus genus within the Togavirus
family. It is the causative agent of rubella and congential
rubella syndrome.54 Only in 2004, rubella virus was iden-
tiﬁed as an etiological agent of Fuchs uveitis syndrome
(FUS).55 Hence, few reports are available on the immunol-
ogy and pathology in Fuchs uveitis (FU) patients with a
conﬁrmed intraocular rubella virus infection. Therefore,
this partwill focusmostly on the immunopathology of FU
in general. Do note, however, that HCMV and more
recently chickungunya virus have also been reported to
be associated with FUS-like clinical entities and that in
most reports on FUS, it is not clearwhich virus is involved
in the population described.2,37,56
Striking immunopathological features of FUS are
iris atrophy/heterochromia and the stellate keratic
precipitates and vitritis.9,57 Electronmicroscopical
(EM) and IHC studies on iris biopsies of FUS patients
revealed the abundant presence of plasma cells and
other lymphocytes, abnormal or degraded melano-
cytes, the absence of stromal melanocytes, stromal
atrophy, and depigmentation of the posterior pigment
epithelium consistent with the described atrophy and/
or heterochromia.58–62 Indeed, in longitudinal studies,
gradual degeneration of the stroma and posterior pig-
mented epithelium resulting in the clear blue iris, typi-
cal of the diseased eye in bright eyed FUS patients, has
been described as well.63,64 IHC analysis on iris and
cornea biopsies also showed mononuclear cell and
particularly plasma cell inﬁltration in Koeppe nodules
and keratic precipitates, respectively.58,62 Although it
is not known whether the patients investigated in
these studies had rubella virus-associated FUS, the
presence of plasma cells would be in agreement with
the high prevalence of intraocular antibody production
against rubella virus.55,65–68 Unfortunately, the magni-
ﬁcation of the EM pictures was too low to observe
rubella virus particles should these have been present.
In addition to plasma cells, T cells were found in the
anterior chamber ﬂuid of FUS patients.60,69,70 Muhaya
et al. described the presence of both CD4 and CD8 T
cells in the AH of FUS patients. Both T-cell subsets were
present at higher frequencies than in paired peripheral
blood. Moreover, there seemed to be a shift toward CD8
T cells, which was also observed by Laballette et al.69,70
Unfortunately, the distinction between cytotoxic T cells
and regulatory CD8 T cells was not made. Both IFN-γ and
IL-10 expression were found in the AH of the FUS
patients, suggesting that both CD8 T-cell subsets might
be present. Laballette et al. investigated the clonal compo-
sition of intraocular CD8 T cells of two FUS patients by
analyzing the expression of T-cell receptor variable beta
(TCRVβ) genes.69 The authors found a limited number of
TCRVβ clonotypes in both patients suggestive of an anti-
gen-driven process, though it was not determined
whether this intraocular T-cell response was directed to
an infectious agent, such as rubella virus, or self-antigens
or both.
Whereas no clear genetic associations with speciﬁc
HLA alleles have been described for FUS, Spriewald
et al. reported an association between polymorphisms
in the cytotoxic T-lymphocyte antigen 4 (CTLA4)
gene.57,71 However, these data have to be corroborated
in a larger patient cohort.
In intraocular ﬂuid of FUS patients, expression of
several, mostly inﬂammatory, cytokines, and chemo-
kines has been reported, including IL-6, IL-8, IL-12, IL-
15, IP-10, MCP-1, TNF-α, INF-γ, and MIP-1α.
Interestingly, with the exception of IL-12, expression of
most inﬂammatory immune mediators was decreased
compared to that in HSV-1 and VZV-induced posterior
(acute retina necrosis) and anterior uveitis, reﬂecting the
low-grade inﬂammation in FUS eyes.25,72 Similarly, de
Visser et al. reported a surprising similarity between
chemo-/cytokine expression levels in AH of FUS and
ocular toxoplasmosis patients, apparently representative
of a milder inﬂammatory pathogenesis.72 Anti-inﬂam-
matory cytokines, such as TGF-β and IL-10, have been
detected in FUS AH as well, though IL-10 expression in
AH was generally low and not signiﬁcantly different
compared to non-inﬂammatory controls.13,25,70,72 Suzuki
et al., however, found high IL-10 expression levels in the
vitreous of two FUS patients.13 Since there are no other
reports on cytokine expression in vitreous of FUS
patients, the implication of these discrepant ﬁndings is
not clear yet.
In conclusion, the immunopathology of FUS is char-
acterized by a low-grade intraocular antigen-driven
inﬂammation with T-cell and plasma cell inﬁltration
and mild inﬂammatory immune mediator expression,
with currently no apparent genetic associations. In
case of rubella virus, one could envisage a pathogen-
esis where a slow viral infection results in gradual
degradation of the anterior layer, stroma, and poster-
ior pigmented epithelium of the iris. Furthermore, in
reaction to the viral infection, plasma cells, T cells, and
monocytes/macrophages inﬁltrate in the eye, which in
combination with cytokine and chemokine expression
also contribute to tissue damage to the iris and to
immune depositions on the cornea and iris.
SUMMARY
HSV, VZV, CMV, and rubella virus are the major etiolo-
gies of virus-induced anterior uveitis and together cause a
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variety of anterior uveitis manifestations which may not
only have speciﬁc characteristics but may also overlap,
despite the fact that each virus has its own distinctive
pathogenic properties.9,37 Whereas active HSV/VZV
and CMV AU are characterized by acute lytic infections,
rubella virus-related AU is slowly progressing and does
not seem to cause immediate virus-related tissue damage.
HSV and VZV are self-limiting infections that establish a
lifelong latent infection in neurons of ganglia that are kept
under control by both innate and adaptive immune
responses. If immune control fails, the endogenous latent
virus reactivates and may cause a variety of recrudescent
ocular diseases including AU. CMV infection is also self-
limiting; however, this virus is not neurotropic but seems
to become latent in ocular-resident cells, although a low-
grade persistent infection cannot be ruled out. If left
untreated, HCMV can cause frequent intermittent recur-
rences. Rubella virus infection on the other hand does not
seem to cease and may represent a long-lasting persistent
low-grade infection ultimately culminating in the typical
ophthalmoclinical manifestations of FUS probably as a
result of continuous immunological activity. From an
immunological perspective, ocular infection with the
aforementioned viruses results in the inﬂux of T and B
cells rather than neutrophils, and a proinﬂammatory
immune mediator proﬁle, though the anti-inﬂammatory
cytokine IL-10 is also expressed, possibly to counteract the
inﬂammation. The combined knowledge suggests that
the outcome of an intraocular viral infection is largely
guided by the characteristics of the virus, which subse-
quently dictates the severity and type of the immune
response. The immunological conditions for intraocular
viral control and reactivation or for prolonged inﬂamma-
tion remain subject of investigation.
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